Alnylam Pharmaceuticals (ALNY) Change in Account Payables (2009 - 2019)
Alnylam Pharmaceuticals posted quarterly Change in Account Payables of -$30.1 million for Q3 2019, down 431.18% year-on-year from $9.1 million in Q3 2018, and down 169.16% on a QoQ basis from $43.5 million in Q2 2019.
Alnylam Pharmaceuticals (ALNY) has 11 years of Change in Account Payables data on file, last reported at -$30.1 million in Q3 2019.
- For the quarter ending Q3 2019, Change in Account Payables fell 431.18% year-over-year to -$30.1 million; the trailing twelve-month figure through Sep 2019 stood at $12.4 million (up 6.22% YoY), and the FY2018 full-year result was $15.5 million, up 413.38% from the prior year.
- Change in Account Payables for Q3 2019 stood at -$30.1 million, down from $43.5 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $43.5 million in Q2 2019 and bottomed at -$30.1 million in Q3 2019.
- The 5-year median for Change in Account Payables is $347000.0 (2016), against an average of $978631.6.
- The widest annual swing landed in 2017, when Change in Account Payables slumped 3289.34%; it then surged 6377.34% in 2019.
- A 5-year view of Change in Account Payables shows it stood at $2.6 million in 2015, then jumped by 351.39% to $11.6 million in 2016, then gained by 6.68% to $12.3 million in 2017, then jumped by 30.78% to $16.1 million in 2018, then plunged by 286.56% to -$30.1 million in 2019.
- The last three Change in Account Payables figures came in at -$30.1 million (Q3 2019), $43.5 million (Q2 2019), and -$17.1 million (Q1 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 16.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -30.09 Mn |
| Sep 30, 2019 | -30.09 Mn |
| Jun 30, 2019 | 43.50 Mn |
| Jun 30, 2019 | 43.50 Mn |
| Mar 31, 2019 | -17.13 Mn |
| Mar 31, 2019 | -17.13 Mn |
| Dec 31, 2018 | 16.13 Mn |
| Dec 31, 2018 | 16.13 Mn |
| Sep 30, 2018 | 9.09 Mn |
| Sep 30, 2018 | 9.09 Mn |
| Jun 30, 2018 | -693,000.00 |
| Jun 30, 2018 | -693,000.00 |
| Mar 31, 2018 | -9.04 Mn |
| Mar 31, 2018 | -9.04 Mn |
| Dec 31, 2017 | 12.33 Mn |
| Dec 31, 2017 | 12.33 Mn |
| Sep 30, 2017 | -8.95 Mn |
| Sep 30, 2017 | -8.95 Mn |
| Jun 30, 2017 | 2.74 Mn |
| Jun 30, 2017 | 2.74 Mn |
| Mar 31, 2017 | -11.07 Mn |
| Mar 31, 2017 | -11.07 Mn |
| Dec 31, 2016 | 11.56 Mn |
| Dec 31, 2016 | 11.56 Mn |
| Sep 30, 2016 | 2.13 Mn |
| Sep 30, 2016 | 2.13 Mn |
| Jun 30, 2016 | -3.94 Mn |
| Jun 30, 2016 | -3.94 Mn |
| Mar 31, 2016 | 347,000.00 |
| Mar 31, 2016 | 347,000.00 |
| Dec 31, 2015 | 2.56 Mn |
| Dec 31, 2015 | 2.56 Mn |
| Sep 30, 2015 | 310,000.00 |
| Sep 30, 2015 | 310,000.00 |
| Jun 30, 2015 | -1.95 Mn |
| Jun 30, 2015 | -1.95 Mn |
| Mar 31, 2015 | 750,000.00 |
| Mar 31, 2015 | 750,000.00 |
| Dec 31, 2014 | 9.67 Mn |
| Dec 31, 2014 | 9.67 Mn |
| Sep 30, 2014 | -947,000.00 |
| Sep 30, 2014 | -947,000.00 |
| Jun 30, 2014 | 1.50 Mn |
| Jun 30, 2014 | 1.50 Mn |
| Mar 31, 2014 | -1.38 Mn |
| Mar 31, 2014 | -1.38 Mn |
| Dec 31, 2013 | 3.17 Mn |
| Dec 31, 2013 | 3.17 Mn |
| Sep 30, 2013 | -1.81 Mn |
| Sep 30, 2013 | -1.81 Mn |
| Jun 30, 2013 | 1.43 Mn |
| Jun 30, 2013 | 1.43 Mn |
| Mar 31, 2013 | -959,000.00 |
| Mar 31, 2013 | -959,000.00 |
| Dec 31, 2012 | -1.03 Mn |
| Dec 31, 2012 | -1.03 Mn |
| Sep 30, 2012 | -426,000.00 |
| Sep 30, 2012 | -426,000.00 |
| Jun 30, 2012 | 1.18 Mn |
| Jun 30, 2012 | 1.18 Mn |
| Mar 31, 2012 | -1.46 Mn |
| Mar 31, 2012 | -1.46 Mn |
| Dec 31, 2011 | 314,000.00 |
| Dec 31, 2011 | 314,000.00 |
| Sep 30, 2011 | -2.46 Mn |
| Sep 30, 2011 | -2.46 Mn |
| Jun 30, 2011 | 2.15 Mn |
| Jun 30, 2011 | 2.15 Mn |
| Mar 31, 2011 | -3.51 Mn |
| Mar 31, 2011 | -3.51 Mn |
| Dec 31, 2010 | 2.75 Mn |
| Dec 31, 2010 | 2.75 Mn |
| Sep 30, 2010 | -3.84 Mn |
| Sep 30, 2010 | -3.84 Mn |
| Jun 30, 2010 | 3.41 Mn |
| Jun 30, 2010 | 3.41 Mn |
| Mar 31, 2010 | -5.50 Mn |
| Mar 31, 2010 | -5.50 Mn |
| Dec 31, 2009 | 4.06 Mn |
| Dec 31, 2009 | 4.06 Mn |
| Sep 30, 2009 | 1.96 Mn |
| Sep 30, 2009 | 1.96 Mn |